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)n .  Dua l
ra tments
SuurMARy
N'femory is not unique to the human mind. In contrast .  The abi l i ty  to store
informat ion is essent ia l  to al l  animal l i fe.  Without i t ,  the most elementary
forms of  learning would have been impossible.  Even the most .pr imit ive,
animals l ike worms and mol luscs possess this basic capaci ty.  More complex
animals,  l ike man and other mammals,  have the capaci ty to store matr ices of
associat ions between percept ions in t ime, space ancl  context .
Our understanding of  the memory of  such patterns is l imi ted. However,  i t
is  recognised that memory in mammals depencls on a structure in the brain
cal led the hippocampus, and on the molecule acetylchol ine.  Both ser ious
clamage to the hippocampus and loss of  the nerve cel ls (neurons) that  secrete
acetylchol ine in the brain resul t  in diminished capaci ty to store new infor-
mat ion .
The hippocampus, named af ter  i ts resemblance to the sea hors e (  híppo =
horse, cot t t ,pr t 's  = sea monster;  Greek),  is  a structure imbedcled in the tempo-
ral  lobe of  the cerebral  cortex.  I t  funct ions as a temporary store and a proc-
essor for  new informat ion.  The acetylchol ine secret ing (chol inergic)  f ibres
that reach the hippocampus pla-v an important role in the storage of  informa-
t ion  in  the  h ippocampus.
The chol inergic innervat ion of  the hippocampus or ig inates in the medial
septum' This smal l  structure l ies in the lower- inner part  of  the forebrain and
contains the cel l -bodies that  send their  f ibres to the hippocampus. The re-
lease of  acetylchol ine is determinecl  largely by the electr ical  act iv i ty in septo-
hippocampal f ibres.  In aclc l i t ion,  acetylchol ine released in the medial  septum
is also involved in the r :egulat ion of  h ippocampal act iv i ty.
Acetylchol ine in the hippocampus has been the focus of  a considerable re-
search ef for t -  Beside the scient i f ic  interest  in the biological  substrate of
memory'  these ef for ts are mot ivated by the discovery that  degenerat ion of
the hippocampus and i ts chol inergic innervat ion is an important feature of
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Alzheimer 's disease. Alzheimer 's disease is the rnost common neurodegenela-
t ive c l isease, af fect ing about 20% of al l  indiv iduals above B0 years of  age.
Disor ientat ion and loss of  short  term memoïy,  which are character ist ic to the
ear ly '  stages of  the disease, are largeiy at t r ibutecl  to low levels of  acetylcho-
l ine in the hippocampus and cerebral  cortex.  Consecluent ly,  the pharmacol-
ogical  therapy of  Alzheimer 's disease consists mainly of  drugs that elevate
acetylchol ine levels in the brain.
Despi te the research ef for ts directed to the chol inergic innervat ion of  the
hippocampus, a pr imar5'  aspect of  th is systems has remained relat ively un-
explored. There is l i t t le known about the factors that  control  the release of
acet5zlchol ine in l iv ing animals.  The reason for th is is that  methods for '
measur ing neurotransmit ters in the funct ioning brain of  exper imental  ani-
mals were not avai lable unt i l  recent l5r .  This has changed with the develop-
ment of  intracerebral  microcl ia lysis in the beginning of  the eight ies.  This
method is essent ia l ly  an appl icat ion of  semi-permeable membranes devel-
oped for the art i f ic ia l  k idne) ' .  A smai l -d iameter membrane tube from an al t i -
f ic ia l  k idney is sealed at  one end and mountecl  on a hol low glass f ibre.  This
construct ion,  the dialysis probe, is implanted b5r surger5'  into the brain of  an
anaesthet ised animal and f ixed onto the skul l .  Art i f ic ia l  cerebrospinal
(brain) f lu id is pumped through the glass f ibre and f lows along the mem-
brane to the out let  of  the probe. Smal l  molecules di f fuse from the surrouncl-
ing brain t issue into the probe through the membrane. The f lu id is col lectecl
at  the out let  and analysed in f ract ions.  The compound to be measured is
separated form other components ancl  quant i f ied.
The release of  a neurotransmit ter  in the structure where the dialysis
probe is placecl  can be est imated by measur ing the amount of  the neuro-
transmit ter  in subsequent dialysate f ract ion.  In addi t ion,  d ia l5rs is probes cat l
be used to administrate drugs direct ly into the brain.  The drug is dissolved
in the inf lowine f lu id and di f fuses outwards into the surrounding brain t is-
s u e .
This thesis descr ibes the development of  a method for studying acetylcho-
l ine release from septo-hippocampal neurons in the rat .  Two dialysis probes
were implanted in each rat ,  one in the hippooampus and one in the medial
septum. Both probes were used for measur ing acetylchol ine,  as wel l  as for
the administrat ion of  c l rugs.  Al l  the exper iments had dual  object ives.  On one
hand, to ident i fy the major factors that  control  the release of  acetylchol ine,
and on the other hand, to evaluate and explore the possibi l i t ies of  th is ex-





W à S  t
a11's i
ace t t
in  se l
v ia  t l
thc  h
Ne
t e l  i s




b v  t h




v ia  t t
re leas
of  C l























r ta l  ani-
develop-
es .  Th is
rs  deve l -
an al t i -
r re .  Th is












is  p robes
Le medial
ell as for
s .  On one
r'lcholine,
f  th is ex-
nique in-
Stunmar '
format ion on the regulat ion of  acetvlchol ine release in al ive and unre-
s t ra ined an imals .
F i i s t ,  we had to  p rove tha t  our  exper imenta i  des ign  worked proper l l ' .  Th is
was done in  th ree  s tages .  F i rs t  we showed tha t  ace ty lcho l ine  measured in  d i -
al l , 's is samples was released from nerve endings. Then, we demonstrated that
acet l ' lchol ine levels in the hippocampus were related to the electr ical  act iv i t l '
in septo-hippocampal f ibres.  Final l ) ' ,  we showed that administrat ion of  drugs
via the dial5. 's is probe in the medial  septum affected acetvlchol ine release in
the  h ippocampus.  The above resu l ts  a re  p resented  in  Chapter  2 .
Ncurons  communica te  b1 , '  re leas ing  neuro t lansmi t te rs .  A  Neuro t ransmi t -
ter  is  re leasecl  f rom nerve endings ancl  b incls to receptors on a receiv ing neu-
ron. The binding of  the neurotransmit ter  to the receptor al ters the act iv i ty of
the receiv ing neuron. Receptor:s are al ,so used as targets for  c l rugs that inf lu-
ence the  communica t ion  be tweer l  neurones .
The release of  acetylchol ine f rom septo-hippocampal neurons is modulated
hv the receptors present on these neurons. The next stage of  the research
was to ident i f -v these receptors by measur ing acetvlchol ine dur ing the ad-
ministrat ion of  drugs that block or st imulate di f ferent receptors types.
Nfost  neuïons have receptors for  the neurotransrni t te l  that  they release
(autoreceptors).  Neurotransmit ters aro bel ieveci  to regulate their  own release
via these autoleceptors (autoinhibi t ion).  The ef fect  of  autoreceptors on the
release of  acety ' lchol ine in the hippocampus and medial  septum is the subject
o f  Chapter  3 .  Auto ih ib i t ion  was present  in  bo th  s t ruc tu res .  l \ {o reover ,
autoinhibi t ion was found to determine the release of  acetylchol ine to great
extent.  However.  autoreceptors in the mecl ia l  septum did not af fect  the elec-
tr ical  act iv i t5 '  in septo-hippocampal f ibres.
In  Chapters  4  and 5 ,  we inves t iga ted  the  invo lvement  o f  two c lasses  o f
receptors that  were l ikely to af fect  acetvlchol ine release in the hippocampus,
namely,  receptors for  the amino-acid neurotransrni t ters glutamate and
GABA. GABA was found to inhibi t  acetylchol ine release in the medial  sep-
tum and the hippocampus cont inuously.  The resul ts also indicated that glu-
tamate  s t imu la tes  ace ty lcho l ine  v ia  leceptors  in  the  med ia l  sep tum,  bu t  re -
c luces acetylchol ine release via receptors in the hippocampus. Glutamate re-
ceptors were,  however,  not  act ivated b5r enclogenous glutamate.  I t  rvas un-
clear in which c i rcumstances glutamate receptors could be involved in the
reeulat ion of  acetvlchol ine release.
Summary-
Benzodiazepines, (e.g.  Val ium),  are commonly used as t ranqui l l isers,
s leep-enhancing drugs and ant iepi lept ics,  and are parts of  most k inds of  an-
aesthesia.  Benzodiazepines act  by enhancing the ef fect  of  GABA. One of  their
s ide ef fects is a temporary relapse of  memory.  The under ly ing cause might be
inhibi t ion of  acetylchol ine release in the hippocampus. To test  th is hypothe-
sis,  we administered a benzodiazepine by in ject ion under the skin
(subcutaneously) ,  or  v ia the dialysis probe in the medial  septum. Subcutane-
ous, but not intraseptal  administrat ion,  decreased acetylchol ine release. This
resul t  support  the idea that a reduct ion in hippocampal acetylchol ine levels
might contr ibute to memory impairment by benzodiazepines. However,
GABA receptor in the medial  septum do not appear to be invoived in th is ef-
fect .  Perhaps the reduct ion in acetylchol ine is caused by the ef fects of  benzo-
cl iazepines on behaviour and the sensi t iv i ty to the environment,  and is not
direct ly relatecl  to the GABAergic inhibi t ion of  septo-hippocampal neurons.
Changes in acetylchol ine release in the hippocampus correspond to
changes in behavioural  act iv i ty.  Per iods of  act iv i ty are accompanied by in-
creases in acetylchol ine levels in the hippocampus and cerebral  cortex.  This
relat ionship between acetylchol ine and behaviour caused problems in ear l ier
stages of  the research, because some of the drugs that were administerecl
also incluced' behavioural activity' This activity affects acet5rlcholine release
and therefore,  i t  is  l ikely to interfere wi th the direct  ef fect  of  the drug on
chol inergic neurons. This problems has been resolved by using anaesthet ised
animals in some exper iments.
In the last  stage of  the research, the same associat ion between acetylcho-
I ine and behaviour was ut i l ised to invest igate the funct ional  s igni f icance of
receptors.  Rats were act ivated by removing them from their  home cage and
holding them in the hand for several  minutes.  This proceclure was also per-
formed during the administration of drugs via the dial} 'sis probe' The in-
volvement of  a receptor in behaviour- induced changes in acetylchol ine re-
lease was invest igated by comparing the behaviour- induced acetylchol ine
release in the presence of  a drug to that  in controls.
In Chapter 7,  we invest igated the involvement of  GABA and glutamate in
the induct ion of  acetylchol ine release dur ing behaviour.  In Chapter 4,  we al-
ready showed that GABA represses acetylchol ine release cont inuously v ia re-
ceptors in the medial  septum. Reduct ion of  th is inhibi t ion might st imulate
chol inergic neurons dur ing behavioural  act iv i ty.  This hypothesis was not









































be excludecl  because the administrat ion of  a GABA analogue in the medial
septum incleased the act iv i ty of  the rats.
Blocking of  g lutamate receptors in the medial  septum reduced the increase
in acetS' lchol ine as incluced by the behavioural  procedure.  Thus, the st imula-
t ion of  g lutamate receptors in the medial  septum is one of  the mechanisms
that cause acet-v- lchol ine to increase dur ing behavioural  act iv i ty.
To measure acet) ' lchol ine wi th our method, i t  is  lecessary to elevate the
levels of  acetylchol ine in the brain.  This was at ta ined by adding a compound
that leduces the metabol ic degradat ion of  acet5r lghol ine (an acetylchol ines-
terase inhibi tor)  to the f lu id in the dialysis probe. The resul t ing increase in
acetylchol ine levels is l ikely to increase the level  of  autoinhibi t ion,  and
might al ter  the normal pattern and pharmacological  propert ies of  acetylcho-
l ine release. Acetylchol inesterase inhibi tors are also used in the therapy of
Alzheimer 's disease to increase acetylchol ine levels in the brain.  Autoinhibi-
t ion might restr ict  the ef fects of  acetylchol inesterase inhibi tors on acet l . lcho-
l ine levels and repress funct ional  changes in acetylchol ine release. The rela-
t ionship between acety ' lchol inesterase inhibi t ion,  autoinhibi t ion and behav-
iour- induced acetylchol ine release is the subject  of  Chapter 6.
First ,  the le lat ion between acetylchol inesterase inhibi t ion and acetylcho-
l ine levels was character ised by administerat ion three di f ferent doses of  an
inhibi tor  through the cl ia lysis protre.  The involvement of  autoinhibi t ion was
visual ised by s imultaneous administrat ion of  a drug that blocks autorecep-
tors.  Rats were act ivated by the behavioural  procedure in al l  these condi t ions
in order to invest igate the ef fects of  acetylchol inesterase inhibi t ion and
autoinhibi t ion on physiological  changes in acetylchoLine release.
Autoinhibi t ion became act ivatecl  only when acetylchol ine levels were in-
creased several  fo ld of  normal levels by acetylchol inesterase inhibi t ion.  How-
ever,  when autoinhibi t ion became act ive,  i t  reducer l  the ef fect  of  acetylcho-
l inesterase inhibi t ion on acetylchol ine levels substant ia l l5 ' .  Hence. large in-
creases in acetylchol ine levels are prevented by autoinhibi t ion.
Behaviour- induced inclease in acetylchol ine levels became relat ivelS'
-smal ler  at  h igher levels of  acetylchol inesterase inhibi t ion.  However,  i t  was
unclear whether th i -s was the resul t  of  autoinhibi t ion.  In the presence of  the
lower doses of  acet5, ' lchol inesterase inhibi tors,  autoinhibi t ion was not de-
tected even when the anirnals wel 'e act ivated and acetylchol ine release in-
creased. Only in presence of  h igher doses of  the acetylchol inesterase inhibi-
tor ,  behaviour- induced increase in acetylchol ine release resul ted in addi-
t ional  autoinhibi t ion onlv in the.  I t  is  c l i f f icul t  to understand the normal
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funct ion of  autoreceptors i f  they are not act ivated in physiological  concl i t ions.
Perhaps their  funct ion is to prevent acetylchol ine f rom 'overshoot ing'  to toxic
va lues .
The most important conclusion of  th is thesis is that  the exper imental  c le-
s ign we cleveloped provides unique informat ion on the chol inergic neurons
the innervate the hippocampus. Receptors that  af fect  the release of  acetyl-
chol ine release can be ident i f ied and studied in al ive and unrestrainecl  ani-
mals.  Moreover,  the method al lows us to invest igate the role of  these recep-
tors in normal changes in acetylchol ine release. Perhaps, the exper imental
design can be appl ied in Alzheimer research. For example,  new and current
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